Skip to content
★ Sign in to follow
HC

HighCape Capital, L.P.

Related company / holding
Aziyo Biologics, Inc.Elutia Inc.
Insider activity · 24 months2 buys0 salesCumulative net flow
Total declarations
12
Company
1
▲ Purchases (7 ops.)
€13.3M
▼ Sales (0 ops.)
—

Latest filing published 13 Mar 2025 for ELUTIA INC., €1.0M.

Filing timeline

BuySale
HighCape Capital, L.P.

Insider track record

Disclosed buys
7
Disclosed sells
0
T+90 hit rate
0%
T+90 mean return
-40.6%

Across 1 buy signal with a settled T+90 return. Return basis: close on the day after publication.

Signal history

HighCape Capital, L.P.: trading record in brief

HighCape Capital, L.P. is a declared insider of Elutia Inc., with filings sourced from SEC (Form 4). We count 12 filings; the first trade dates from 13 October 2020 and the latest from 3 February 2025.

On the market, this insider has only ever bought: 7 purchases, €13.3M in total. The amount is not disclosed for 1 filing. A purchase on the market is a deliberate choice to commit personal money, which is why it draws more attention than a grant. Other entries cover 3 share grants. So far in 2025, the count stands at 2 purchases and no sales.

A typical purchase (the median) is worth €1.2M. 1 out of 5 purchases came within 30 days of a purchase by at least one other insider of the same company. When several insiders buy within a few weeks of each other, analysts speak of a cluster purchase.

The record was last updated on 13 March 2025 with an open-market purchase (€1.0M) in Elutia Inc. Between a trade and the moment it shows up on SEC (Form 4), the median delay is 2 days. US insiders must file a Form 4 within two business days of a trade. Every figure here comes from the filings published by SEC (Form 4) and describes the past, not future prices; it is not investment advice.

Companies and markets linked to HighCape Capital, L.P.

Open company profiles for insider transactions, fundamentals and analyst consensus when available.

Declarations7 total
  • ▲
    Related company / holdingExecutivesElutia Inc.
    1M USD13SEC
    420,000 shares@ US$2.5021.2% of flowClass A Common StockSEC:0001104659-25-023488:0
    Canonical exit: 4 May 2025 (T+90)
  • ▲
    Related company / holdingExecutivesElutia Inc.
    1M USD0SEC
    420,000 shares@ US$2.5021.2% of flowClass A Common StockSEC:0001104659-25-023484:0
    Canonical exit: 4 May 2025 (T+90)
  • ◆
    Related company / holdingExecutivesElutia Inc.
    3M USD17SEC
    2,101,577 shares@ US$1.427557.5% of flowClass A Common StockSEC:0001104659-24-084967:0
  • ●
    Related company / holdingExecutivesElutia Inc.
    0SEC
    1,436,077 sharesClass A Common StockSEC:0001104659-24-002239:0
  • ▲
    Related company / holdingExecutivesElutia Inc.
    0SEC
    2,837,128 sharesClass A Common StockSEC:0001826279-23-000002:0
    Canonical exit: 20 Dec 2021 (T+90)
  • ▲
    Related company / holdingExecutivesAziyo Biologics, Inc.
    3M USD43SEC
    735,000 shares@ US$4.7555.4% of flowClass A Common StockSEC:0001104659-22-125197:0
    Canonical exit: 5 Mar 2023 (T+90)
  • ▲
    Related company / holdingExecutivesAziyo Biologics, Inc.
    1M USD18SEC
    353,773 shares@ US$4.2428.7% of flowClass A Common StockSEC:0001104659-21-148591:0
    Canonical exit: 8 Mar 2022 (T+90)

7 of 7 declarations